{"id":694756,"date":"2026-05-24T09:01:41","date_gmt":"2026-05-24T07:01:41","guid":{"rendered":"https:\/\/podcast.rs\/koronavirus-prepoznavanje-preko-mda5\/"},"modified":"2026-06-13T20:58:10","modified_gmt":"2026-06-13T18:58:10","slug":"koronavirus-prepoznavanje-preko-mda5","status":"publish","type":"post","link":"https:\/\/podcast.rs\/en\/koronavirus-prepoznavanje-preko-mda5\/","title":{"rendered":"Koronavirus \u2013 prepoznavanje preko MDA5"},"content":{"rendered":"<p>U labu 110 (s04e30)<\/p>\n<\/p>\n<p>Snimljeno: 2026-05-22<\/p>\n<p>Mesto: Departman za hemiju, biohemiju i za\u0161titu \u017eivotne sredine, PMF NS<\/p>\n<p>Autori: Sr\u0111an i Milo\u0161<\/p>\n<\/p>\n<p><a href=\"https:\/\/linktr.ee\/ulabu\" target=\"_blank\" rel=\"ugc noopener noreferrer\">\u2060\u2060\u2060\u2060U labu\u2060\u2060\u2060\u2060\u2060\u2060\u2060\u2060\u2060\u2060<\/a><\/p>\n<p><a href=\"https:\/\/discord.gg\/J5ZwstequU\" target=\"_blank\" rel=\"ugc noopener noreferrer\">\u2060\u2060\u2060\u2060\u2060\u2060\u2060Discord\u2060\u2060\u2060\u2060\u2060\u2060\u2060\u2060\u2060\u2060\u2060\u2060\u2060<\/a><\/p>\n<\/p>\n<p>Bele\u0161ke:<\/p>\n<\/p>\n<p>02:10 Uvod 1: rekapitulacija dosada\u0161njih epki o imunitetu, naro\u010dito one o ulasku virusa u \u0107eliju<\/p>\n<p>09:15 Uvod 2: gra\u0111enje DMV \u010destica<\/p>\n<p>12:20: MDA5 &#8211; Melanoma Differentiation-Associated protein 5<\/p>\n<p>RLR &#8211; RIG-I-Like Receptors<\/p>\n<p>RIG-I &#8211; Retinoic acid-Inducible gene I<\/p>\n<p>TLR &#8211; Toll-Like Receptors<\/p>\n<p>CARD &#8211; Caspase Recruitment Domain<\/p>\n<p>26:00 MAVS &#8211; Mitochondrial antiviral-signaling<\/p>\n<p>30:15 TRAF3 &#8211; Tumor necrosis factor Receptor-Associated Factor 3<\/p>\n<p>Ubikvitin i razgradnja proteina, kao i paralelna uloga ubikvitinacije u imunitetu (K63 ubikvitinacija)<\/p>\n<p>37:05 TBK1 &#8211; TANK-binding kinase 1<\/p>\n<p>TANK &#8211; TRAF gamily member-Associated NF-Kappa B activatorKinaze kao va\u017ene farmaceutske mete<\/p>\n<p>Fosforilovanje kao na\u010din kontrole kinaznog supstrata (\u010desto proteina)<\/p>\n<p>42:55 IRF3 &#8211; Interferon Regulatory Factor 3<\/p>\n<p>45:40 IFN-\u03b2 &#8211; InterFeroN Beta<\/p>\n<p>Citokini kao posebni \u0107elijski glasnici razli\u010diti od hormona i neurotransmitera<\/p>\n<p>NF-\u03baB &#8211; Nuclear Factor kappa-light-chain-enhancer of activated B cells<\/p>\n<p>50:10 Rekapitulacija puta, zavr\u0161ni komentari najava pri\u010de o NF-\u03baB<\/p>\n<\/p>\n<p>\u2060\u2060\u2060\u2060<a href=\"https:\/\/tinyurl.com\/s04e30MDA5\" target=\"_blank\" rel=\"ugc noopener noreferrer\">Reference<\/a>\u2060\u2060\u2060\u2060\u2060\u2060\u2060\u2060\u2060\u2060\u2060 (a\u017eurira\u0107emo)<\/p>","protected":false},"excerpt":{"rendered":"<p>U labu 110 (s04e30) Snimljeno: 2026-05-22 Mesto: Departman za hemiju, biohemiju i za\u0161titu \u017eivotne sredine, PMF NS Autori: Sr\u0111an i Milo\u0161 \u2060\u2060\u2060\u2060U labu\u2060\u2060\u2060\u2060\u2060\u2060\u2060\u2060\u2060\u2060 \u2060\u2060\u2060\u2060\u2060\u2060\u2060Discord\u2060\u2060\u2060\u2060\u2060\u2060\u2060\u2060\u2060\u2060\u2060\u2060\u2060 Bele\u0161ke: 02:10 Uvod 1: rekapitulacija dosada\u0161njih epki o imunitetu, naro\u010dito one o ulasku virusa u \u0107eliju 09:15 Uvod 2: gra\u0111enje DMV \u010destica 12:20: MDA5 &#8211; Melanoma Differentiation-Associated protein 5 RLR &#8211;&#8230;<\/p>","protected":false},"author":3,"featured_media":88484,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[543],"tags":[],"class_list":["post-694756","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-u-labu"],"_links":{"self":[{"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/posts\/694756","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/comments?post=694756"}],"version-history":[{"count":2,"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/posts\/694756\/revisions"}],"predecessor-version":[{"id":694933,"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/posts\/694756\/revisions\/694933"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/media\/88484"}],"wp:attachment":[{"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/media?parent=694756"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/categories?post=694756"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/tags?post=694756"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}